Piperidinyl substituted cyclohexane-1,4-diamines

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/445 (2006.01) C07D 221/26 (2006.01)

Patent

CA 2602151

The present invention relates to piperidine substituted cyclohexane-1,4- diamine compounds of Formula (I) and pharmaceutically acceptable forms thereof, as a1a/a1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as method of treatments.

L'invention concerne des composés de cyclohexane-1,4-diamine à substitution pipéridine représentés par la formule (I) et des formes de ceux-ci pharmaceutiquement acceptables, utilisés comme modulateurs d'adrénorécepteur a1a/a1d pour traiter des symptômes d'hypertrophie bénigne de la prostate et de maladies des voies urinaires inférieures. L'invention concerne également des compositions pharmaceutiques comprenant les nouveaux composés, de nouveaux procédés de préparation de ces composés, de nouvelles méthodes d'utilisation comme médicament ainsi que des méthodes de traitement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperidinyl substituted cyclohexane-1,4-diamines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidinyl substituted cyclohexane-1,4-diamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidinyl substituted cyclohexane-1,4-diamines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1689117

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.